Related Experiment Video
Updated: May 2, 2026
Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones
Published on: November 30, 2016
Management of Oligometastatic Colorectal Cancer
Camille R Suydam1, Andrew T Schlussel2
1Department of General Surgery, 300 East Hospital Road, Fort Eisenhower, GA 30905, USA.
Oligometastatic colorectal cancer management requires specific strategies, often involving surgery or local therapies like SBRT. Adjuvant and neoadjuvant therapies are recommended, while immunotherapy
Area of Science:
- Oncology
- Gastroenterology
Background:
- Oligometastatic colorectal cancer (OMCRC) management differs significantly from widely metastatic disease.
- Familiarity with OMCRC treatment options is crucial for clinicians.
Purpose of the Study:
- To outline current management strategies for oligometastatic colorectal cancer.
- To highlight the importance of tailored treatment approaches for OMCRC patients.
Main Methods:
- Review of current treatment modalities for OMCRC.
- Discussion of surgical, local ablative therapies, and adjuvant/neoadjuvant chemotherapy.
Main Results:
- Surgical intervention is often definitive for OMCRC.
- Stereotactic body radiation therapy (SBRT) and other ablative techniques are viable local options.
- Adjuvant therapy is recommended for all patients; neoadjuvant chemotherapy should be considered.
Conclusions:
- Treatment for OMCRC should be individualized.
- The role of immunotherapy in OMCRC is currently limited due to insufficient clinical trial data.
More Related Videos
08:54Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
